{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T20:15:48Z","timestamp":1778703348156,"version":"3.51.4"},"reference-count":87,"publisher":"FapUNIFESP (SciELO)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Acad. Bras. Ci\u00eanc."],"published-print":{"date-parts":[[2005,9]]},"abstract":"<jats:p>A bibliographic search has been performed in MEDLINE using cortisol and panic as key-words, occurring in the title and\/or in the abstract. Human studies were selected, with no time limit. The following publications were excluded: reviewarticles, case reports, panic attacks in disorders other than panic disorder, and studies on changes that occurred in-between panic attacks. The results showed that real-life panic attacks as well as those induced by selective panicogenic agents such as lactate and carbon dioxide do not activate the hypothalamicpituitary- adrenal (HPA) axis. Agonists of the colecystokinin receptor B, such as the colecystokinin-4 peptide and pentagastrin, increase stress hormones regardless of the occurrence of a panic attack and thus, seem to activate the HPA axis directly. The benzodiazepine antagonist flumazenil does not increase stress hormones, but this agent does not reliably induce panic attacks. Pharmacological agents that increased anxiety in both normal subjects and panic patients raised stress hormone levels; among them are the alpha2-adrenergic antagonist yohimbine, the serotonergic agents 1-(m-chlorophenyl) piperazine (mCPP) and fenfluramine, as well as the psychostimulant agent caffeine. Therefore, the panic attack does not seem to activate the HPAaxis, in contrast to anticipatory anxiety.<\/jats:p>","DOI":"10.1590\/s0001-37652005000300009","type":"journal-article","created":{"date-parts":[[2006,1,9]],"date-time":"2006-01-09T13:33:37Z","timestamp":1136813617000},"page":"477-491","source":"Crossref","is-referenced-by-count":47,"title":["Does the panic attack activate the hypothalamic-pituitary-adrenal axis?"],"prefix":"10.1590","volume":"77","author":[{"given":"Frederico G.","family":"Graeff","sequence":"first","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cybele","family":"Garcia-Leal","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina M.","family":"Del-Ben","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco S.","family":"Guimar\u00e3es","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/archpsyc.1990.01810160095016","article-title":"Cholecystokinin-4 and panic","volume":"47","author":"ABELSON JL","year":"1990","journal-title":"Arch Gen Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0003-990X","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0006-3223(94)91188-6","article-title":"Pentagastrin infusions in patients with panic disorder: II. Neuroendocrinology","volume":"36","author":"ABELSON JL","year":"1994","journal-title":"Biol Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0006-3223","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF02191958","article-title":"Anxiogenic properties of yohimbine: I. Behavioral, physiological and biochemical measures","volume":"241","author":"ALBUS M","year":"1992","journal-title":"Eur Arch Psychiatry Clin Neurosci","ISSN":"https:\/\/id.crossref.org\/issn\/0940-1334","issn-type":"print"},{"key":"ref4","series-title":"Diagnostic and statistical manual of mental disorders","year":"1980","edition":"3"},{"key":"ref5","series-title":"Diagnostic and statistical manual of mental disorders","year":"1994","edition":"4"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1006\/frne.1993.1004","article-title":"Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age","volume":"14","author":"ANTONI FA","year":"1993","journal-title":"Front Neuroendocrinol","ISSN":"https:\/\/id.crossref.org\/issn\/0091-3022","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0165-1781(92)90142-P","article-title":"Functional interrelationship of serotonin and norepinephrine: cortisol response to MCPP and DMI in patients with panic disorder, patients with depression, and normal controls","volume":"43","author":"ASNIS GM","year":"1992","journal-title":"Psychiatry Res","ISSN":"https:\/\/id.crossref.org\/issn\/0165-1781","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/02698811030173002","article-title":"Does the brain noradrenaline network mediate the effects of the CO2 challenge?","volume":"17","author":"BAILEY JE","year":"2003","journal-title":"J Psychopharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0269-8811","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1176\/appi.ajp.157.3.454","article-title":"Salivary cortisol in panic attacks","volume":"157","author":"BANDELOW B","year":"2000","journal-title":"Am J Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0002-953X","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0022-3956(97)00021-6","article-title":"Acute inositol does not attenuatem-CPP-induced anxiety, mydriasis and endocrine effects in panic disorder","volume":"31","author":"BENJAMIN J","year":"1997","journal-title":"J Psychiatr Res","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3956","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0022-3999(97)00203-1","article-title":"Neurobiology of panic disorder","volume":"44","author":"BOURIN M","year":"1998","journal-title":"J Psychosom Res","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3999","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/070674379003500115","article-title":"Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder","volume":"35","author":"BRADWEJN J","year":"1990","journal-title":"Can J Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0706-7437","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archpsyc.1991.01810310021005","article-title":"Enhanced sensitivity to cholecystokinin-tetrapeptide in panic disorder: Clinical and behavioral findings","volume":"48","author":"BRADWEJN J","year":"1991","journal-title":"Arch Gen Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0003-990X","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00004850-200015030-00004","article-title":"Increased psychological responses and divergent neuroendocrine responses to m-CPP and ipsapirone in patients with panic disorder","volume":"15","author":"BROOCKS A","year":"2000","journal-title":"Int Clin Psychopharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0268-1315","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0306-4530(87)90061-8","article-title":"Endocrine and physiological changes during \"spontaneous\" panic attacks","volume":"12","author":"CAMERON OG","year":"1987","journal-title":"Psychoneuroendocrinol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1152\/ajplegacy.1914.33.2.356","article-title":"The emergency function of the adrenal medulla in pain and the major emotions","volume":"33","author":"CANNON WB","year":"1914","journal-title":"Am J Physiol","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9513","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1176\/ajp.143.4.483","article-title":"Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy","volume":"143","author":"CARR DB","year":"1986","journal-title":"Am J Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0002-953X","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1001\/archpsyc.1985.01790260027003","article-title":"Increased anxiogenic effects of caffeine in panic disorders","volume":"42","author":"CHARNEY DS","year":"1985","journal-title":"Arch Gen Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0003-990X","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1176\/ajp.144.8.1030","article-title":"Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks","volume":"144","author":"CHARNEY DS","year":"1987","journal-title":"Am J Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0002-953X","issn-type":"print"},{"key":"ref20","first-page":"14","article-title":"Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects","volume":"92","author":"CHARNEY DS","year":"1987","journal-title":"Psychopharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1001\/archpsyc.55.2.130","article-title":"Plasma cortisol concentrations preceding lactate-induced panic: psychological, biochemical, andphysiological correlates","volume":"55","author":"COPLAN JD","year":"1998","journal-title":"Arch Gen Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0003-990X","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/026988119100500414","article-title":"5-HT and mechanisms of defence","volume":"5","author":"DEAKIN JFW","year":"1991","journal-title":"J Psychopharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0269-8811","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0165-1781(90)90096-N","article-title":"Behavioral, neuroendocrine, and biochemical effects of 5-hydroxytryptophan administration in panic disorder","volume":"31","author":"DEN BOER JA","year":"1990","journal-title":"Psychiatry Res","ISSN":"https:\/\/id.crossref.org\/issn\/0165-1781","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0306-4530(00)00015-9","article-title":"Neurohormonal responses to cholecystokinin tetrapeptide: a comparison of younger and older healthy subjects","volume":"25","author":"FLINT AJ","year":"2000","journal-title":"Psychoneuroendocrinol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.psychres.2004.04.010","article-title":"Anxiety and salivary cortisol in symptomatic and nonsymptomatic panic patients and healthy volunteers performing simulated public speaking","volume":"133","author":"GARCIA-LEAL C","year":"2004","journal-title":"Psychiatry Res","ISSN":"https:\/\/id.crossref.org\/issn\/0165-1781","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0165-1781(94)90001-9","article-title":"Response to meta-chlorophenylpiperazine in panic disorder patients and healthy subjects: influence of reduction in intravenous dosage","volume":"54","author":"GERMINE M","year":"1994","journal-title":"Psychiatry Res","ISSN":"https:\/\/id.crossref.org\/issn\/0165-1781","issn-type":"print"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1176\/ajp.141.7.857","article-title":"Response to hyperventilation in a group of patients with panic disorder","volume":"141","author":"GORMAN JM","year":"1984","journal-title":"Am J Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0002-953X","issn-type":"print"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0193-953X(05)70342-7","article-title":"Serotonergic systems","volume":"20","author":"GRAEFF FG","year":"1997","journal-title":"Psychiat Clin N Am"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neubiorev.2003.12.004","article-title":"Serotonin, the periaqueductal gray and panic disorder","volume":"28","author":"GRAEFF FG","year":"2004","journal-title":"Neurosci Biobehav Rev","ISSN":"https:\/\/id.crossref.org\/issn\/0149-7634","issn-type":"print"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1590\/S0100-879X2003000400003","article-title":"Pharmacology of human experimental anxiety","volume":"36","author":"GRAEFF FG","year":"2003","journal-title":"Braz J Med Biol Res","ISSN":"https:\/\/id.crossref.org\/issn\/0100-879X","issn-type":"print"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0022-3999(98)00027-0","article-title":"Experimental pathophysiology of panic","volume":"45","author":"GRIEZ E","year":"1998","journal-title":"J Psychosom Res","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3999","issn-type":"print"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/026988118700100305","article-title":"Effect of chlorimipramine and maprotiline on experimental anxiety in humans","volume":"1","author":"GUIMAR\u00c3ES FS","year":"1987","journal-title":"J Psychopharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0269-8811","issn-type":"print"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0165-1781(97)00041-3","article-title":"Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls","volume":"71","author":"GURGUIS GN","year":"1997","journal-title":"Psychiatry Res","ISSN":"https:\/\/id.crossref.org\/issn\/0165-1781","issn-type":"print"},{"key":"ref34","first-page":"3","article-title":"The story of flumazenil","volume":"2","author":"HAEFELY WE","year":"1988","journal-title":"Eur J Anesthesiol Suppl"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00004714-199602000-00014","article-title":"Addition of d-fenfluramine to benzodiazepines produced a marked improvement in refractory panic disorder - a case report","volume":"16","author":"HETEM LAB","year":"1995","journal-title":"J Clin Psychopharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0271-0749","issn-type":"print"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/archpsyc.1989.01810020037007","article-title":"Cortisol and sodium lactate-induced panic","volume":"46","author":"HOLLANDER E","year":"1989","journal-title":"Arch Gen Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0003-990X","issn-type":"print"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0278-5846(94)90064-7","article-title":"Serotonergic function in panic disorder: endocrine responses to D-fenfluramine","volume":"18","author":"JUDD FK","year":"1994","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0278-5846","issn-type":"print"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF00216062","article-title":"Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder","volume":"96","author":"KAHN RS","year":"1988","journal-title":"Psychopharmacol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/0024-3205(92)90543-X","article-title":"Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man","volume":"50","author":"KELLNER M","year":"1992","journal-title":"Life Sci","ISSN":"https:\/\/id.crossref.org\/issn\/0024-3205","issn-type":"print"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1176\/ajp.152.9.1365","article-title":"Possible role of atrial natriuretic hormone in pituitary-adrenocortical unresponsiveness in lactate-induced panic","volume":"152","author":"KELLNER M","year":"1995","journal-title":"Am J Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0002-953X","issn-type":"print"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s002130050371","article-title":"Influence of clonidine on psychopathological, endocrine and respiratory effects of cholecystokinin tetrapeptide in patients with panic disorder","volume":"133","author":"KELLNER M","year":"1997","journal-title":"Psychopharmacol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-3956(97)00034-4","article-title":"Atrial natriuretic hormone in lactate-induced panic attacks: mode of release and endocrine and pathophysiological consequences","volume":"32","author":"KELLNER M","year":"1998","journal-title":"J Psychiatry Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.psyneuen.2004.01.009","article-title":"Effects of propranolol on symptom and endocrine responses to pentagastrin","volume":"29","author":"KHAN S","year":"2004","journal-title":"Psychoneuroendocrinol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/archpsyc.1993.01820160076009","article-title":"False suffocation alarms, spontaneous panics and related conditions: An integrative hypothesis","volume":"50","author":"KLEIN DF","year":"1993","journal-title":"Arch Gen Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0003-990X","issn-type":"print"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0006-3223(91)90119-7","article-title":"Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects","volume":"30","author":"KLEIN E","year":"1991","journal-title":"Biol Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0006-3223","issn-type":"print"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0165-1781(87)90058-8","article-title":"Pituitary adrenocortical unresponsiveness in lactate-induced panic","volume":"21","author":"LEVIN AP","year":"1987","journal-title":"Psychiatry Res","ISSN":"https:\/\/id.crossref.org\/issn\/0165-1781","issn-type":"print"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/archpsyc.1985.01790300077010","article-title":"Lactate provocation of panic attacks: II. Biochemical and physiological findings","volume":"42","author":"LIEBOWITZ MR","year":"1985","journal-title":"Arch Gen Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0003-990X","issn-type":"print"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0165-1781(91)90020-P","article-title":"Elevated serum lactate associated with panic attacks induced by hyperventilation","volume":"38","author":"MADDOCK RJ","year":"1981","journal-title":"Psychiatry Res","ISSN":"https:\/\/id.crossref.org\/issn\/0165-1781","issn-type":"print"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/0097840X.1975.9940399","article-title":"A historical review of stress","volume":"1","author":"MASON JW","year":"1975","journal-title":"J Hum Stress"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0893-133X(96)00197-2","article-title":"A comparison of the effects of intravenous pentagastrin on patients with social phobia, panic disorder and healthy controls","volume":"16","author":"MCANN UD","year":"1997","journal-title":"Neuropsychopharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0893-133X","issn-type":"print"},{"key":"ref51","first-page":"172","article-title":"The neurobiology of stress: from serendipity to clinical relevance","volume":"886","author":"MCEWEN BS","year":"2000","journal-title":"Brain Res","ISSN":"https:\/\/id.crossref.org\/issn\/0006-8993","issn-type":"print"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF00436092","article-title":"Simulated public speaking as a model of clinical anxiety","volume":"77","author":"MCNAIR DM","year":"1982","journal-title":"Psychopharmacol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neubiorev.2004.03.005","article-title":"A two-dimensional neuropsychology of defense: fear \/ anxiety and defensive distance","volume":"28","author":"MCNAUGHTON N","year":"2004","journal-title":"Neurosci Biobehav Rev","ISSN":"https:\/\/id.crossref.org\/issn\/0149-7634","issn-type":"print"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s002139900342","article-title":"d-Fenfluramine in panic disorder: a dual role for 5-hydroxytryptamine","volume":"149","author":"MORTIMORE C","year":"2000","journal-title":"Psychopharmacol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1001\/archpsyc.1990.01810220033004","article-title":"Flumazenil provocation of panic attacks Evidence for altered benzodiazepine receptor sensitivity in panic disorder","volume":"47","author":"NUTT DJ","year":"1990","journal-title":"Arch Gen Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0003-990X","issn-type":"print"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0006-3223(98)00053-5","article-title":"Sodium lactate and hypertonic sodium chloride induce equivalent panic incidence, panic symptoms, and hypernatremia in panic disorder","volume":"44","author":"PESKIND ER","year":"1998","journal-title":"Biol Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0006-3223","issn-type":"print"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJM196712212772502","article-title":"Lactate metabolism in anxiety neurosis","volume":"277","author":"PITTS FN","year":"1967","journal-title":"N Engl J Med","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0278-5846(96)00102-9","article-title":"Carbon dioxide induced panic attack in panic disorder in Japan","volume":"20","author":"SASAKI I","year":"1996","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0278-5846","issn-type":"print"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0149-7634(01)00060-4","article-title":"Modeling panic attacks","volume":"25","author":"SCHENBERG LC","year":"2001","journal-title":"Neurosci Biobehav Rev","ISSN":"https:\/\/id.crossref.org\/issn\/0149-7634","issn-type":"print"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00213-002-1072-8","article-title":"L-5-hydroxytryptophan induced increase in salivary cortisol in panic patients and healthy volunteers","volume":"161","author":"SCHRUERS K","year":"2002","journal-title":"Psychopharmacol"},{"key":"ref61","first-page":"2630","article-title":"Autonomic reactivity and hormonal secretion in lactate-induced panic attacks","volume":"272","author":"SEIER FE","year":"1997","journal-title":"Am J Physiol","ISSN":"https:\/\/id.crossref.org\/issn\/0002-9513","issn-type":"print"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/138032a0","article-title":"A syndrome produced by diverse nocuous agents","volume":"138","author":"SELYE H","year":"1936","journal-title":"Nature","ISSN":"https:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"},{"key":"ref63","first-page":"332","article-title":"Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder","volume":"22","author":"SHLIK J","year":"1997","journal-title":"J Psychiatry Neurosci","ISSN":"https:\/\/id.crossref.org\/issn\/1180-4882","issn-type":"print"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-1781(99)00029-3","article-title":"Panic induced by carbon dioxide inhalation and lack of hypothalamic-pituitary-adrenal axis activation","volume":"86","author":"SINHA SS","year":"1999","journal-title":"Psychiatry Res","ISSN":"https:\/\/id.crossref.org\/issn\/0165-1781","issn-type":"print"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1176\/ajp.151.4.621b","article-title":"Controlling panic attacks with fenfluramine","volume":"151","author":"SOLYOM L","year":"1994","journal-title":"Am J Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0002-953X","issn-type":"print"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1176\/ajp.155.5.610","article-title":"Effect of flumazenil in lactate-sensitive patients with panic disorder","volume":"155","author":"STROHLE A","year":"1998","journal-title":"Am J Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0002-953X","issn-type":"print"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0006-3223(98)00295-9","article-title":"Behavioral, neuroendocrine, and cardiovascular response to flumazenil: no evidence for an altered benzodiazepine receptor sensitivity in panic disorder","volume":"45","author":"STROHLE A","year":"1999","journal-title":"Biol Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0006-3223","issn-type":"print"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0893-133X(99)00115-3","article-title":"Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder","volume":"22","author":"STROHLE A","year":"2000","journal-title":"Neuropsychopharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0893-133X","issn-type":"print"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0006-3223(90)90428-5","article-title":"Differential responses to anxiogenic challenge studies in patients with major depressive disorder and panic disorder","volume":"28","author":"TARGUM SD","year":"1990","journal-title":"Biol Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0006-3223","issn-type":"print"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0306-4530(92)90003-P","article-title":"Cortisol response during different anxiogenic challenges in panic disorder patients","volume":"17","author":"TARGUM SD","year":"1992","journal-title":"Psychoneuroendocrinol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0165-1781(89)90210-2","article-title":"Fenfluramine provocation of anxiety in patients with panic disorder","volume":"28","author":"TARGUM SD","year":"1989","journal-title":"Psychiatry Res","ISSN":"https:\/\/id.crossref.org\/issn\/0165-1781","issn-type":"print"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/frne.1998.0172","article-title":"Forebrain pathways mediating stress-induced hormone secretion","volume":"20","author":"VAN DE KAR LD","year":"1999","journal-title":"Front Neuroendocrinol","ISSN":"https:\/\/id.crossref.org\/issn\/0091-3022","issn-type":"print"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1192\/bjp.144.5.503","article-title":"Panic symptoms after the inhalation of carbon dioxide","volume":"144","author":"VAN DEN HOUT MA","year":"1984","journal-title":"Br J Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0007-1250","issn-type":"print"},{"key":"ref74","first-page":"386","article-title":"Salivary cortisol in panic: are males more vulnerable?","volume":"25","author":"VAN DUINEN MA","year":"2004","journal-title":"Neuro Endocrinol Lett"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF02249335","article-title":"Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients","volume":"114","author":"VAN MEGEN HJ","year":"1994","journal-title":"Psychopharmacol"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0924-977X(96)00018-1","article-title":"The panic-inducing properties of the cholecystokinin tetrapeptide CCK4 in patients with panic disorder","volume":"6","author":"VAN MEGEN HJ","year":"1996","journal-title":"Eur Neuropsychopharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0924-977X","issn-type":"print"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s002130050186","article-title":"The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients","volume":"129","author":"VAN MEGEN HJ","year":"1997","journal-title":"Psychopharmacol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0924-977X(95)00070-6","article-title":"Behavioral, neuroendocrine and biochemical effects of different doses of 5-HTP in panic disorder","volume":"6","author":"VAN VLIET IM","year":"1996","journal-title":"Eur Neuropsychopharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0924-977X","issn-type":"print"},{"key":"ref79","first-page":"858.11","article-title":"Pharmacological and endocrinological properties of intracranially-induced panic-like behaviors","volume":"27","author":"VARGAS LC","year":"2001","journal-title":"Soc Neurosci Abstr"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF00444706","article-title":"Serotonin function in panic disorder: effect of l-5-hydroxytryptophan in patients and controls","volume":"98","author":"WESTENBERG HG","year":"1989","journal-title":"Psychopharmacol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0165-1781(96)02001-X","article-title":"Serotonin function in panic disorder: intravenous administration of meta-chlorophenylpiperazine","volume":"64","author":"WETZLER S","year":"1996","journal-title":"Psychiatry Res","ISSN":"https:\/\/id.crossref.org\/issn\/0165-1781","issn-type":"print"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/archpsyc.1987.01800160077010","article-title":"Situational panic attacks: Behavioral, physiologic, and biochemical characterization","volume":"44","author":"WOODS SW","year":"1987","journal-title":"Arch Gen Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0003-990X","issn-type":"print"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archpsyc.1988.01800250051007","article-title":"Carbon dioxide induced anxiety: behavioral, physiologic, and biochemical effects of carbon dioxide in patients with panic disorders and healthy subjects","volume":"45","author":"WOODS SW","year":"1988","journal-title":"Arch Gen Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0003-990X","issn-type":"print"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0165-1781(91)90124-8","article-title":"Behavioral, biochemical and cardiovascular responses to the benzodiazepine receptor antagonist flumazenil in panic disorder","volume":"36","author":"WOODS SW","year":"1991","journal-title":"Psychiatry Res","ISSN":"https:\/\/id.crossref.org\/issn\/0165-1781","issn-type":"print"},{"key":"ref85","series-title":"The ICD-10 classification of mental and behavioral disorders","year":"1992"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0893-133X(01)00266-4","article-title":"Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers","volume":"25","author":"ZWANZGER P","year":"2001","journal-title":"Neuropsychopharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0893-133X","issn-type":"print"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/sj.npp.1300131","article-title":"Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study","volume":"28","author":"ZWANZGER P","year":"2003","journal-title":"Neuropsychopharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0893-133X","issn-type":"print"}],"container-title":["Anais da Academia Brasileira de Ci\u00eancias"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/aabc\/v77n3\/a09v77n3.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,13]],"date-time":"2019-04-13T23:15:02Z","timestamp":1555197302000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0001-37652005000300009&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":87,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0001-37652005000300009"],"URL":"https:\/\/doi.org\/10.1590\/s0001-37652005000300009","relation":{},"ISSN":["0001-3765"],"issn-type":[{"value":"0001-3765","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}